|
Support dave.md
Dave.md strives to be the premier independent resource on diabetes and vascular disease on the World Wide Web. We derive our operating revenue through a combination of grants, individual donations, and advertising. As a not-for-profit 501(c)(3) corporation according to the United States Internal Revenue Service, all contributions made to dave.md are fully tax deductible.
Individuals
Please consider supporting dave.md through a tax deductible donation. Once you complete your donation, you will receive a receipt for your records. You can securely make a one-time or recurring donation using Paypal, major credit/debit card, or your bank account.
Institutions
We welcome sponsorship from private-sector corporations and foundations for unrestricted educational grants or support for discrete activities such as CME. For more information, contact Josh Murphy, Managing Editor.
About dave.md
dave.md seeks to increase the knowledge and understanding of the inter-relationships between diabetes and cardiovascular disease within the scientific and medical communities.
It is our goal to provide users with access to credible, concise, cutting-edge information in a user-friendly online environment.
The management of diabetes is a global concern. Few disease states are as common as or have the health implications of diabetes. Although diabetes is a disorder of the
"insulin-glucose axis," the major pathobiology occurs in the vascular system. It is quite clear in the modern era of medical treatment that the primary cause of mortality
and major morbidity in the diabetic patient is directly attributable to both macro and microvascular complications. In fact, 70 percent of all case-fatalities among diabetic
patients are a net result of a cardiovascular complication.
Additionally, the world population of people affected with type 2 diabetes is increasing at an alarming rate. It is projected that 300 million people will
have diabetes worldwide by 2025. Although initially thought to be a disease of developed nations, the vast majority of new cases over the next 20 years will be in developing
countries. Given the financial burden and the requisite clinical infrastructure needed to care for these high-risk individuals, major efforts will be required to deliver adequate
care to the world population.
As the link between diabetes and cardiovascular disease grows, health care providers must be kept up-to-date on the latest disease management strategies.
dave.md was designed with this in mind. Our global Editorial Board is comprised of individuals with an international reputation for leadership in the field of diabetes and cardiovascular disease.
dave.md is managed by DiaVed, Inc., a 501(c)(3) nonprofit organization in Kansas City, Missouri, specializing in diabetes and vascular educational resources for physicians and scientists.
Note: Information contained within this site is intended to support and not replace the patient-physician relationship.
Staff
Steve Marso, MD
Dr. Marso serves as the Editor-in-Chief for dave.md. He is also an Interventional Cardiologist and investigator with the Mid America Heart Institute in Kansas City, Missouri, and Associate Professor of Medicine at the University
of Missouri-Kansas City. His research focuses primarily on the link between pre-diabetes and cardiovascular disease. He is also Co-Chairman of the Diabetes Summit, an annual CME event at American Heart Association Scientific Sessions, Senior Editor of
of Diabetes and Vascular Disease Research, the official journal of the International Society of Diabetes and Vascular Disease, and founder and board member of the International Society of Diabetes & Vascular Disease Research.
Joseph (Josh) Murphy, MBA
Mr. Murphy serves as the Managing Editor and Senior Medical Writer for dave.md. He is also a Project Manager for diabetes and cardiovascular educational programs
at the Mid America Heart Institute. He is responsible for content development and daily operations for dave.md.
John House, MS
Mr. House is a Biostatistician at the Mid America Heart Institute in Kansas City, Missouri, and serves as Chief Financial Officer for dave.md
Last updated: July 27, 2007
|
